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The age-related loss of muscle mass and strength has been attributed to the limited myogenic capacity 
of satellite cells (SC). However, the majority of studies evaluating SC function has been performed in 
vitro and only a very limited number of studies have evaluated their function in vivo. PURPOSE: we 
used our established xenograft model to test whether the myogenic capacity of SC from muscles 
isolated from human cadavers, across a range of different ages, is maintained after being transplanted 
to mice. METHODS: Strips of human muscles derived from different donors were transplanted into 
the anterior compartment of the mouse leg (after removal of the tibialis anterior and extensor digitorum 
longus muscles), followed by closure of the skin with surgical glue and stainless-steel wound clips. At 
3- and 6-weeks post-surgery, animals were euthanized and muscles were quickly dissected and snap 
frozen. Frozen muscles were then immunostained and imaged using specific antibodies. Statistical 
analyses performed by one-way ANOVA with multiple comparisons. RESULTS: all human muscle 
samples that successfully regenerated showed a similar regenerative capacity regardless of the age of 
the donor (from 36 to 78 years of age).  Additionally, we found no apparent decline in the regenerative 
capacity of human SCs with extended postmortem intervals (from 4 to 11 days postmortem). Our 
results also showed that muscle fiber sizes were similar between all regenerated muscles at 3 weeks 
post post-transplant. CONCLUSION: Our findings demonstrate that the age-related loss in muscle 
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mass is not attributed to ineffective satellite cell myogenic function but is potentially due to an inimical 
environment that does not favor the myogenicity of these cells. 
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